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Abstract
In rod-shaped bacteria, the bacterial actin ortholog MreB is considered to organize the incorporation of cell wall precursors
into the side-wall, whereas the tubulin homologue FtsZ is known to tether incorporation of cell wall building blocks at the
developing septum. For intracellular bacteria, there is no need to compensate osmotic pressure by means of a cell wall, and
peptidoglycan has not been reliably detected in Chlamydiaceae. Surprisingly, a nearly complete pathway for the
biosynthesis of the cell wall building block lipid II has been found in the genomes of Chlamydiaceae. In a previous study, we
discussed the hypothesis that conservation of lipid II biosynthesis in cell wall-lacking bacteria may reflect the intimate
molecular linkage of cell wall biosynthesis and cell division and thus an essential role of the precursor in cell division. Here,
we investigate why spherical-shaped chlamydiae harbor MreB which is almost exclusively found in elongated bacteria (i.e.
rods, vibrios, spirilla) whereas they lack the otherwise essential division protein FtsZ. We demonstrate that chlamydial MreB
polymerizes in vitro and that polymerization is not inhibited by the blocking agent A22. As observed for MreB from Bacillus
subtilis, chlamydial MreB does not require ATP for polymerization but is capable of ATP hydrolysis in phosphate release
assays. Co-pelleting and bacterial two-hybrid experiments indicate that MreB from Chlamydophila (Chlamydia) pneumoniae
interacts with MurF, MraY and MurG, three key components in lipid II biosynthesis. In addition, MreB polymerization is
improved in the presence of MurF. Our findings suggest that MreB is involved in tethering biosynthesis of lipid II and as
such may be necessary for maintaining a functional divisome machinery in Chlamydiaceae.
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Introduction
The cytoskeletal protein MreB, a bacterial ortholog of actin, is
widely distributed in rods, vibrios and spirilla and absent in most
spherical bacteria [1,2]. Escherichia coli, Bacillus subtilis and
Caulobacter crescentus mreB knock-out mutants lose their typical
shape and generate enlarged cells showing major morphological
defects [3,4,5].
MreB belongs to the actin/Hsp70 superfamily, a functionally
highly divergent group of proteins including heat shock proteins,
sugar kinases and the plasmid stability protein ParM. They share
limited amino acid identity but have a common fold that consists
of two major symmetric domains folding around a nucleotide
binding pocket [1]. Mg
2+ or Ca
2+ dependent ATP hydrolysis of
these proteins is coupled to conformational changes which are
known to regulate the activity of Hsp70 and the dynamic assembly
of actin polymers [6].
MreB polymers are thought to tether incorporation of cell wall
precursors into the side-wall during longitudinal growth [1] by
recruiting and functionally organizing enzymes involved in cell
wall precursor biosynthesis including soluble (MurB, MurC,
MurE, MurF) and membrane (MraY and MurG) proteins [7].
The MreB organized enzyme machinery is connected to the PBP2
catalyzed precursor polymerization reactions on the outside
through a membrane-spanning complex containing MreC, MreD
and RodA [3,7,8]. The MreB protein self-assembles into
filamentous polymeric structures in vitro and was considered to
organize into helical filaments at the inner leaflet of the
cytoplasmic membrane in vivo [1]. Based on total internal reflection
fluorescence microscopy experiments, a recent study revealed that
MreB assembles into discrete patches in B. subtilis, E. coli and C.
crescentus [9]. A model for side-wall elongation in B. subtilis was
proposed where MreB patches restricted the lateral diffusion of
membrane-spanning wall elongation complexes to organize
insertion of cell wall precursors along bands largely perpendicular
to the long cell axis.
MreB polymers are dynamic structures that undergo cell cycle-
related changes to reorganize into circumferential rings that flank
the cytokinetic FtsZ ring. The cytoskeletal MreB rings are
suggested to be involved in the division and segregation of the
bacterial cytoskeleton and show interactions with MreC, MreD
and RodA as well [10].
The tubulin ortholog FtsZ is almost ubiquitously distributed in
bacteria, archaea and eukaryotic organelles [11] and is considered
to be a central organizer of prokaryotic cell division. It assembles
into an annular structure (Z-ring) at midcell and initiates cell
division by attracting a set of proteins to form the cell divison
machinery [11]. FtsZ is known to tether PBP3 (FtsI) catalyzed
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[12].
Cell division and cell wall biosynthesis in prokaryotic cells are
both driven by partially overlapping, tightly co-ordinated
machineries. For intracellular bacteria such as Chlamydiaceae, there
is no need to maintain osmotic stabilization by means of a cell wall,
and peptidoglycan has not been reliably detected in Chlamydiaceae
so far [13]. Nevertheless, antibiotics that target cell wall
biosynthesis are also active against Chlamydiaceae, a paradox known
as the chlamydial anomaly [13]. A nearly complete pathway for
peptidoglycan biosynthesis has been found in the genomes of
Chlamydiaceae [13], and activity of MurA, MurC/Ddl, CT390,
DapF, MurE, MraY and MurG has been demonstrated
[13,14,15,16].
Recently, we discussed the hypothesis that maintaining lipid II
biosynthesis in cell wall-less bacteria reflects an essential role of the
lipid II biosynthesis pathway for prokaryotic cell division [16]. The
aim of the present study is to gain understanding of the
organization of lipid II biosynthesis in Chlamydiaceae. Surprisingly,
these endobacteria lack the apparently essential division protein
FtsZ, but harbor, despite their spherical shape, MreB [17].
Here, we demonstrate that chlamydial MreB polymerizes in vitro
and interacts with key components in lipid II biosynthesis. Our
findings suggest that MreB is involved in directing lipid II
biosynthesis to the septum and as such may be necessary for
maintaning a functional divisome machinery in Chlamydiaceae.
Results
MreB from C. pneumoniae polymerizes in vitro
To examine the functionality of MreB from C. pneumoniae,w e
tested whether this protein can polymerize in vitro, as shown
recently for MreB from Thermotoga maritima (MreB1) [18] and
Bacillus subtilis [19]. We overproduced MreB from C. pneumoniae in
E. coli and purified the recombinant protein. Chlamydial MreB
polymerized in vitro in light scattering and sedimentation assays
(Fig. 1 and Fig. 2b (left panel)). Polymerization was favored at low
pH values and in the presence of Mg
2+ ions but inhibited by K
+
ions (Fig. 1 A–C). The chlamydial protein showed more similarity
to MreB from B. subtilis than to MreB from T. maritima regarding
its pH and K
+ dependance. Polymerization of MreB from C.
pneumoniae and B. subtilis was greatly impaired or completely
inhibited at pH values of $8 and strongly inhibited at KCl
concentrations of 20 mM. In contrast, MreB from T. maritima was
shown to polymerize at pH as high as 9.5 and in presence of
20 mM KCl [18]. These properties probably reflect the
adaptation of this extremophilic organism to geothermally heated
marine sediments.
Polymerization of MreB from C. pneumoniae is not
inhibited by S-(3,4-Dichlorobenzyl)isothiourea (A22) in
vitro
A22 is widespread applied to disrupt the cell cycle-related
reorganization of the bacterial MreB cytoskeleton causing defects
in cell morphology. The compound impairs the ATP dependent
polymerization of T. maritima MreB in vitro by competitively
binding into the nucleotide-binding pocket of the protein [20]. We
investigated the effect of A22 on MreB polymerization using light
scattering and sedimentation assays. Both experiments revealed
that A22 did not impair the polymerization of chlamydial MreB in
vitro (Fig. 2).
In a previous study [21], seven A22-resistant stable mutants
from Caulobacter crescentus were generated under A22 selection
pressure. All mutants showed amino acid exchanges in MreB
which could be mapped to the nucleotide-binding pocket of the
protein and affected residues that were conserved in MreB from C.
crescentus, T. maritima and E. coli. One of these altered residues in
mutant C. crescentus MreB is intrinsically exchanged in wild-type
MreB from C. pneumoniae (Ala345 located in helix 12 is replaced by
cysteine, numbering of C. pneumoniae). To test whether this natural
alteration in chlamydial wild-type MreB is responsible for
insusceptibility to A22, we replaced Cys345 with alanine and
investigated the effect of A22 on the mutant protein. Interestingly,
the C345A mutant showed the same phenotype like the wild-type
protein in that its polymerization was not affected by A22 (Fig. 2b).
In vitro polymerization of C345A mutant and wild-type
MreB proteins is independent of the presence of ATP
To further analyze the insusceptibiliy of chlamydial MreB to
A22, we tested whether chlamydial MreB might be capable of
polymerizing in the absence of nucleotides (Fig. 3). Remarkably,
both the C345A mutant and wild-type MreB proteins polymer-
ized in the same time course and to the same extent in the
absence or presence of ATP. To exclude that MreB-bound, co-
purified nucleotides might have driven polymerization indepen-
dent from the addition of ATP, we treated the purified MreB
wild-type and C345A mutant protein solutions with an anion
exchange resin prior to use, as described previously for nucleotide
exchange procedures for MreB [18,19]. The so-treated MreB
species still polymerized without the addition of ATP (data not
shown).
Therefore, it appears reasonable that a competitive inhibitor of
nucleotide binding such as A22 cannot block the polymerization of
chlamydial MreB proteins. In the presence of GTP, the kinetics
and extent of wild-type MreB polymerization was impaired
(Fig. 3b). Binding of GTP to the nucleotide binding pocket of
chlamydial MreB might introduce conformational changes that
impact on the polymerization process. Our findings on ATP
independent polymerization are consistent with previous in vitro
results on MreB from Bacillus subtilis which showed that the
purified actin ortholog polymerized in a nucleotide independent
fashion [19].
C345A mutant and wild-type MreB proteins from C.
pneumoniae hydrolyze ATP in vitro
MreB from B. subtilis does not require nucleotides for
polymerization but can hydrolyze ATP [19]. To test whether
chlamydial MreB is a functional ATPase, we performed phosphate
release assays (Fig. 4). The C345A mutant and wild-type MreB
proteins hydrolyzed ATP without marked differences. Using buffer
conditions that do not allow polymerization, monomeric MreB
hydrolysed ATP continuously during the whole time of the
experiment (1 h). In contrast, under standard polymerization
conditions ATPase activity was stalled once polymerization of
MreB was completed (after 15 min), and phosphate release
reached only approximately one third of the level measured for
monomeric MreB. These results indicate that ATPase activity is
associated with the monomeric stage of MreB.
A22 had no inhibitory effect on ATP hydrolysis in all
experiments. This indicates that the compound cannot bind to
the nucleotide binding pocket of both the wild-type and the
C345A mutant MreB.
Chlamydial MreB interacts with MurF, MraY and MurG
We examined the interactions of MreB with MurF, MraY and
MurG, three key enzymes involved in cell wall biosynthesis. The
ligase MurF attaches the dipeptide D-Ala-D-Ala to the UDP-N-
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synthesis of the first membrane bound intermediate by transfering
N-acetylmuramic acid-pentapeptide to the lipid carrier undecapre-
nyl phosphate yielding lipid I. Subsequently, MurG adds N-
acetylglucosamine yielding the final peptidoglycan precursur lipid II.
We detected interaction of MreB with MurF in vitro using a co-
pelleting assay that monitors for MreB polymerization in the
presence of MurF. MurF co-pelleted with MreB polymers and did
not pellet on its own (Fig. 5). In a control containing BSA and
MreB, BSA remained in the supernatant and did not interact with
Figure 1. Polymerization of wild-type MreB from C. pneumoniae. In vitro light scattering assays were performed at varying pH (a) MgCl2 (b)
and KCl (c) concentrations using 5 mM MreB.
doi:10.1371/journal.pone.0025129.g001
Figure 2. Influence of A22 on the polymerization of chlamydial MreB. The effect of A22 on MreB wild-type and C345A mutant
polymerization was determined by light scattering (a) and sedimentation assays (b). For sedimentation assays, polymerized MreB proteins were
centrifuged and equivalent volumes of supernatants and pellets were separated on a SDS-PAGE.
doi:10.1371/journal.pone.0025129.g002
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tration of MreB (5 mM) constant and increasing the concentration
of MurF (2.5 mM, 5 mM, 10 mM, 15 mM), MreB polymerized to
an increasing extent and spun down in the pellet. At a molar ratio
of 1:3 (MreB:MurF), roughly all MreB polymerized and was
recovered in the pellet. These results indicate that polymerization
of MreB is favored in the presence of MurF.
A bacterial adenylate cyclase two-hybrid system (BACTH
system, Euromedex, France) was used for analysing interactions
between MreB, MraY and MurG in vivo. Bacterial two-hybrid
analysis confirmed our results on in vitro polymerization of MreB in
that self-interaction was detected (Fig. 6). Additionally, we found
MreB interacting with both the integral membrane protein MraY
and the membrane associated cytosolic MurG. As expected from
the localisation of the N-terminal adenylate cyclase fragments,
these interactions showed relatively low b-galactosidase activities.
In fusion with MraY, the adenylate cyclase fragment was located
in the periplasm (predicted from topology studies [22], and using
topology prediction program TMHMM [23]). Fused with MurG,
the respective fragment was located closed to the membrane
association site of the protein (predicted from the crystal structure
[24]).
Discussion
Like many other bacteria occupying a defined and narrow
ecological niche (e.g., Mycoplasma pneumoniae, [25], Rickettsia conorii
[26]), all members of Chlamydiaceae have a remarkable reduced
genome size [17]. In the course of adaptation to the isotonic host
cell enviroment they apparently could afford to lose a functional
cell wall. They also lost the cell division driving FtsZ but retained
the cytoskeletal protein MreB and a lipid II biosynthesis pathway.
Cell division and cell wall biosynthesis in prokaryotes are driven by
partially overlapping multiprotein machineries whose activity
needs to be tightly co-ordinated to maintain cell integrity.
Recently, we proposed that conservation of lipid II biosynthesis
in cell wall-lacking endobacteria may reflect the intimate
molecular linkage of cell wall biosynthesis and cell division and
thus a vital role of the bactoprenol bound precursor in cell division
[16]. In this study, we investigated whether MreB plays a role in
organizing lipid II biosynthesis in Chlamydiaceae. We showed that
chlamydial MreB interacts with MurF, MraY and MurG, three
key components of lipid II biosynthesis. Additionally, MreB was
functional and polymerized in vitro. Polymerization of chlamydial
MreB was favored in the presence of MurF but, as shown recently
for B. subtilis MreB [9], strongly inhibited at K
+ concentrations as
low as 20 mM. In vivo studies proved that MreB from B. subtilis is
able to polymerize under physiological conditions (e.g. [9,27]) with
K
+ concentrations of about 300 mM [28]. Interplay of enhancing
mechanisms (protein interaction) and inhibitory mechanisms (salt
susceptibility) may contribute to modulate and control the
polymerization of MreB in vivo.
Chlamydial MreB and MurG interact with each other (this
study). MurG is functionally conserved in C. pneumoniae and
transfers N-acetylglucosamine onto lipid I yielding lipid II in vitro
[16]. Moreover, these two proteins have been shown to localize at
Figure 3. Influence of nucleotides on MreB polymerization. Polymerization of chlamydial wildtype and C345A mutant MreB was investigated
in the presence and absence of ATP (a) and GTP (b) using light scattering assays under standard conditions.
doi:10.1371/journal.pone.0025129.g003
Figure 4. ATPase activity of wild-type and C345A mutant MreB under monomeric (A) and polymerizing (B) conditions. To quantify
ATP hydrolysis phosphate release was measured using a molybdate:malachite green assay. Wild-type and C345A mutant MreB (5 mM) were incubated
with ATP (200 mM) under standard polymerizing and non-polymerizing conditions.
doi:10.1371/journal.pone.0025129.g004
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recent hypothesis that lipid II biosynthesis may have to be
maintained for functional cell division [16], MreB could be
involved in maintaining co-ordinated cell division via tethering the
biosynthesis of lipid II to the chlamydial septum.
Our hypothesis regarding chlamydial MreB is supported by a
recent study on L-forms of Bacillus subtilis [31]. L-form strains are
wall-deficient spherical derivatives of common bacteria which
divide indefinitely. The stable L-forms generated in the study by
Leaver et al. did not require FtsZ for cell-division [31]. These
authors postulated a FtsZ independent extrusion-resolution
mechanism in which a cytoskeletal system (such as builded up
by B. subtilis actin orthologs MreB, Mbl or MreBH) or an active
chromosome segregation system might provide active force
generation. L-form mutants which lacked a D-Alanine racemase
that converts L-Alanine into D-Alanine could grow in the absence
of D-Alanine, and electron microscopy studies revealed no hints of
residual cell wall outside the boundary of the cytoplasm or at the
division site. Because chlamydiae also lack a cell wall and might
not be able to synthesize D-Alanine in absence of a D-Alanine
racemase, these findings are in good agreement with our previous
hypothesis that the monomeric precursor lipid II – possibly with
an uncommon structure of the peptide-side chain lacking D-
Alanine – is required for cell division in Chlamydiaceae [16].
It appears that an entire cycle of lipid II biosynthesis and
processing, including translocation to the outside and recycling of
the bactoprenol carrier, needs to be maintained for co-ordinated
function of the divisome machinery. The fate of lipid II in
chlamydiae is unclear. These endobacteria encode the flippase
FtsW, an integral membrane protein which translocates the
precursor across the membrane [17,32]. Moreover, they harbor
two genes encoding monofunctional transpeptidases (PBP2 and
PBP3 (FtsI)) [17], which cross-link glycan chains via peptide
bridges in free-living bacteria. They also encode a D-alanyl-D-
alanine carboxypeptidase (PBP6a) and a N-acetylmuramyl-L-
alanine amidase (AmiA) [17] which cleaves peptide side chains
from glycan chains during cell division in extracellular bacteria.
The intracellular Chlamydiaceae lack transglycosylases and endo-
peptidases that are needed to link the sugar units of lipid II to form
glycan chains or to cleave peptide bridges between cross-linked
glycan strains, respectively [17]. In addition, they do not posess
pyrophosphorylases which catalyze in E. coli bactoprenol-P
recycling by dephosphorylation of bactoprenol-PP [33]. Moreover,
chlamydial genomes do not encode MreD or MreC, two proteins
which are in elongated bacteria encoded in one operon together
with MreB [17]. During longitudinal growth, MreC and MreD
play a crucial role in connecting the MreB organized precursor
biosynthesis machinery inside the cell with the PBP2 catalyzed
incorporation of cell wall precursors on the outside [7]. For the
spherical bacteria, shape-maintaining functions and spacial
organizing of PBP2 reactions are dispensible. Therefore, chla-
mydiae may have not retained MreC and MreD.
We propose the following model for a linkage between lipid II
biosynthesis and cell division in chlamydiae (Fig. 7).
MreB interacts with MurF, MraY and MurG and serves as a
scaffold directing lipid II biosynthesis to the septum. The
Figure 5. In vitro interaction of MreB and MuF from C. pneumoniae in co-pelleting assays. For sedimentation assays, MreB was polymerized
in the absence and in the presence of increasing amounts of MurF. After centrifugation, equivalent volumes of supernatants (S) and pellets (P) were
separated on a SDS-PAGE.
doi:10.1371/journal.pone.0025129.g005
Figure 6. Bacterial two hybrid studies on in vivo interactions
between chlamydial MreB, MraY and MurG. Protein interactions
were quantitatively determined by measuring b-galactosidase activities
of three individually selected replicate cotransformants. The b-
galactosidase activities are expressed in Miller Units (change in A420/
min/ml/OD600) as mean values (6 standard deviation). Unpaired t-test
revealed statistical significance in comparision to empty vector negative
control (T256T18), *: two-tailed p-value#0.05, *** two-tailed p-value#
0.001).
doi:10.1371/journal.pone.0025129.g006
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biosynthesis cell division machinery. First, translocation of lipid II
across the membrane is catalyzed by flippase FtsW. Subsequently,
PBP2 and FtsI (as well as probably AmiA) catalyze the release of
the bactoprenol carrier. In the process, a rudimentary (glycan-less
[34]) by-product in which the peptide sidechains are cross-linked
by peptide bonds might result. Recycling of bactoprenol-P remains
unclear in the absense of pyrophoshorylases that have been
described so far to dephoshorylate bactoprenol-PP.
Of note, a recent study showed that in reticulate bodies, the
replicative form of chlamydiae, cell division is arrested by the
second binary fission in the presence of penicillin [35]. Binding of
penicillin to chlamydial PBPs may interrupt processing of lipid II
and cell division might be arrested due to depletion of the
bactoprenol carrier.
Functional analysis of the chlamydial PBPs and AmiA, as well as
determination of the exact structure of lipid II will be necessary to
further understand the processing of the precursor in chlamydiae.
MreB from C. pneumoniae, B. subtilis, and T. maritima show more
than 54% of amino acid identities. Despite these high sequence
similarities, these proteins differ regarding requirements on
nucleotides for polymerization their susceptibility towards A22.
All actin orthologs are functional ATPases. However, in contrast
to MreB from T. maritima, the proteins from B. subtilis and C.
pneumoniae polymerize in the absence of ATP (this study, [18,19]).
A22 is frequently used for in vivo studies on the bacterial MreB
cytoskeleton. This compound could be identified in vitro as a
competitive inhibitor of ATP binding to MreB from T. maritima
[20]. The minimal inhibitory concentration (MIC) of A22 towards
B. subtilis is extremely high (100 mg/L) and almost as high as
towards S. aureus (.100 mg/L), a species lacking MreB [36]. In
accordance with our findings on ATP independent polymeriza-
tion, A22 did not inhibit polymerization of chlamydial wild-type
and C345A mutant MreB in vitro. Additionally, A22 did not inhibit
ATP hydrolysis indicating that the compound cannot bind to the
nucleotide binding pocket of MreB from C. pneumoniae. In vitro
experiments on the polymerization and the ATPase activity of B.
subtilis MreB in presence of A22 may be helpful to elucidate,
whether the B. subtilis protein is not a target of A22, as shown in
this study for MreB from C. pneumoniae.
A22 affects bacterial growth not only by acting on MreB but
also on (an)other essential unknown target(s). This has been shown
in several recent reports on (i) E. coli mutants that lack MreB, (ii) an
A22 resistant Anabaena mutant strain retaining a wild-type mreB
gene, and (iii) rod-shaped bacteria containing (C. crescentus) or not
containing MreB (Sinorhizobium meliloti, Agrobacterium tumefaciens)
[37,38]. Further studies dealing with the in vivo effect of A22 on
chlamydiae, bacteria with small genomes and A22-insusceptible
MreB, might be useful for the identification of these unknown
targets.
Orchestration of lipid II biosynthesis and processing as well as
cell division may be achieved by formation of multi-enzyme
complexes. Additional studies on the interaction of MreB with
proteins involved in these fundamental processes will be helpful for
Figure 7. Proposed model for co-ordination of lipid II biosynthesis and cell division in chlamydiae. A complete cycle of lipid II
biosynthesis and processing, including translocation to the outside and recycling of the bactoprenol carrier, needs to be maintained for co-ordinated
function of the cell division machinery (which may consist of FtsW, FtsI, FtsH, FtsK and FtsY). The actin ortholog MreB functionally organizes MurF,
MraY and MurG and directs lipid II biosynthesis to the septum. The synthesized precursor is translocated to the outside where the release of the
bactoprenol carrier is catalyzed through the activity of FtsI and PBP2 (as well as probably AmiA). Question marks and dashed arrows indicate steps of
the proposed pathway that remain to be elucidated. (GlcNAc: N-acetylglucosamine; MurNAc: N-acetylmuramic acid).
doi:10.1371/journal.pone.0025129.g007
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organizing lipid II biosynthesis at the septum and as such in
maintaining a functional division machinery. Deeper insight in co-
ordination of lipid II biosynthesis and cell division will contribute
to elucidate the inscrutable chlamydial anomaly at a molecular
level. In addition, it will provide a basis for the design of new
antibacterial drugs to combat diseases caused by these major
intracellular pathogens.
Materials and Methods
Cloning of chlamydial mreB
The mreB gene from C. pneumoniae GiD [39] was amplified by
PCR using the primers mreB-1 (59-gatgaattcagtccacatcgcaatctg-39)
and mreB-2 (59-ccactcgagtaccaaattccctttacg-39) (restriction sites
are underlined). The PCR product was digested by EcoR1 and
XhoI and ligated into the EcoR1/XhoI site of the vector pET-21b
(Novagen, VWR International, Darmstadt, Germany) such that
MreB carried a C-terminal His6 tag. The correctness of the mreB
sequence was confirmed by sequencing.
Site-directed mutagenesis
Cys345 in chlamydial MreB was changed to alanine using the
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent
Technologies, Waldbronn, Germany). The primers mreB-C345A-
sense (59-catcctttgctggcagttgctttaggaaccgggaaagc-39) and mreB-
C345A-antisense (59-gctttcccggttcctaaagcaactgccagcaaaggatg-39)
(C345A resulting base changes are underlined) were used
according to the manufacturers’ instructions. The correct base
changes were confirmed by sequencing.
MreB overproduction and purification
For the overproduction of wild-type and C345A mutant MreB
proteins, the appropriate vector was transformed into E. coli
BL21(DE3) (New England Biolabs, Frankfurt, Germany). Cultures
were grown at 30uC in LB broth supplemented with 100 mg/L
ampicillin. At an optical density (OD600) of 0.5–0.6, induction was
achieved by the addition of IPTG to a final concentration of
0.5 mM and incubation for 4 h at 30uC. Cells were harvested by
centrifugation (7,0006g for 10 min at 4uC) and stored at 220uC.
The cell pellet of one liter culture was suspended in 6 ml lysis
buffer (50 mM Tris-HCl, 300 mM NaCl, pH 8). Lysozyme was
added to a final concentration of 0.5 mg/ml and cell suspension
was incubated at room temperature for 30 min followed by
sonication and centrifugation (15,0006g for 30 min at 4uC). For
purification of the His-tagged protein from the supernatant, the
cleared lysate was incubated with 1 ml of washed and equilibrated
Ni
2+-nitrilotriacetic acid (Ni-NTA) resin (Qiagen, Hilden, Ger-
many) for 1 hour at 4uC. The Ni-NTA resin was then packed into
gravity-flow columns, washed two times with 5 ml lysis buffer
containing 10 mM and 20 mM imidazole, respectively. His-
tagged protein was eluted using 3 ml of elution buffer (50 mM
Tris-HCl, 300 mM NaCl, 250 mM imidazole, pH 8) and
collected in 0.5 ml fractions. The purified proteins were analyzed
by SDS-PAGE stained with Coomassie blue. The elution fractions
containing the proteins were dialysed against 5 mM Tris-HCl
buffer, pH 8 for at least 30 hours. The wild-type and C345A
mutant MreB proteins were quantified using Bradford.
MreB light scattering assays
Polymerization of MreB was investigated using light scattering
assays described previously by Bean and Aman [18] with slight
modifications. The standard polymerization reaction contained
5 mM MreB, 200 mM ATP, 5 mM MgCl2, 1 mM EGTA, and
10 mM imidazole buffer, pH 7 in a final volume of 800 ml. The
non-protein components were mixed. Separately on ice, MreB was
mixed with 1/9
th volume of 106 cation exchange buffer (1 mM
MgCl2, 10 mM EGTA) and incubated for 1 min. Polymerization
reaction was initiated by combining the two solutions and
performed at 20uC for 15 min. Polymerization was detected by
quantifying percentage of transmission at 400 nm in a spectro-
photometer. All experiments were performed in triplicate. For A22
inhibition studies, A22 was dissolved in DMSO and added to the
non-protein part of the polymerization reaction in a final
concentration of 5, 50 and 300 mM.
MreB sedimentation assays
Experiments followed the protocol of Bean and Amann [18].
Briefly, MreB (5 mM) was polymerized under standard conditions
in presence and absence of 300 mM A22 for 1 hour at 20uC.
Polymerized MreB was centrifuged and equivalent volumes of
pellet and supernatant were analyzed by SDS-PAGE and
Coomassie Blue.
MreB and MurF co-pelleting assays
In vitro interaction of MreB with MurF was investigated
following a previously described copelleting protocol [40].
The sedimentation assays described above were performed with
MreB (5 mM) polymerized in presence and absence of 5 mM
chlamydial MurF. Controlling precipitation of MurF or unspecific
protein interactions, MurF (15 mM) was tested in the absence of
MreB, and MreB was tested in the presence of BSA (15 mM),
respectively. After centrifugation, supernatants were removed for
analysis and pellets were washed with polymerization buffer.
Equivalent volumes of pellet and supernatant were analyzed by
SDS-PAGE and Coomassie Blue.
Phosphate release assays
To analyse ATPase activity of MreB we investigated phosphate
release using a molybdate:malachite green assay [41]. Wild-type
and C345A mutant MreB were incubated with ATP using
standard polymerizing and non-polymerizing (in the absence of
MgCl2, pH 8) conditions. Control reactions without ATP and
without MreB were done as well. After different time intervals,
100 ml aliquots were removed and mixed directly with 5 ml ice cold
70% perchloric acid (Merck, Darmstadt, Germany) to stop the
enzymatic reaction. The so treated reaction was incubated on ice
for 10 minutes and centrifuged for 5 minutes at 49,5006g, 4uC.
The supernatant was mixed with equal volume of Molybdate Dye
Solution (Promega, Mannheim, Germany) and incubated in
microtiter plate for 30 minutes at room temperature. Absorbance
was measured at 600 nm in a spectrophotometer. All experiments
were carried out in triplicate.
Bacterial two-hybrid interaction studies
A bacterial adenylate cyclase two-hybrid system (BACTH
system, Euromedex, France) was used for in vivo interaction
studies between MreB, MraY and MurG. Briefly, the T25 and
T18 fragments of the catalytic domain of Bordetella pertussis
adenylate cyclase were fused to full-lengh copies of each protein.
Each interaction was checked twice with both fusion protein
combinations. For each combination, protein interactions were
quantitatively determined by measuring beta-galactosidase activ-
ities of three individually selected replicate co-transformants.
Additionally, we monitored the background activity due to
interactions of the chlamydial proteins with the T25 and T18
fragments.
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